Status:
COMPLETED
How Long Must the MRI Follow-up Last to Safely Identify Middle Ear Residual Cholesteatoma
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Middle Ear Cholesteatoma
Eligibility:
All Genders
Brief Summary
Previous studies demonstrated the high diagnostic value of non-echoplanar diffusion weighted magnetic resonance imaging (non-EP DWI) for residual cholesteatoma. However, limited data are available reg...
Detailed Description
A retrospective, monocentric study was performed between 2013 and 2019 and included all patients regularly followed-up after canal wall-up tympanoplasty with at least two non-EP DWI performed on the s...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- patients regularly followed-up for middle ear cholesteatoma, who underwent two or more non-EP DWI performed on the same 1.5 Tesla MRI scanner
- Exclusion criteria:
- \- congenital cholesteatomas, tympanoplasty with canal wall-down technique, or suspicion of residual cholesteatoma on the first MRI follow-up
Exclusion
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04489550
Start Date
January 1 2013
End Date
December 31 2019
Last Update
July 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295